https://www.nasdaq.com/press-release/atricure-to-participate-in-the-40th-annual-j.p.-morgan-healthcare-conference-2021-12
https://www.nasdaq.com/press-release/atricure-to-participate-in-upcoming-piper-sandler-33rd-annual-virtual-healthcare
https://www.nasdaq.com/press-release/atricure-reports-third-quarter-2021-financial-results-2021-11-03
https://www.nasdaq.com/press-release/atricure-to-participate-in-upcoming-investor-conferences-2021-10-26
https://www.nasdaq.com/press-release/atricure-to-announce-third-quarter-2021-financial-results-2021-10-05
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-morgan-stanley-19th-annual-global-healthcare
https://www.nasdaq.com/press-release/atricure-reports-second-quarter-2021-financial-results-2021-08-04
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-canaccord-41st-annual-growth-conference-2021-07-30
https://www.nasdaq.com/press-release/atricure-to-announce-second-quarter-2021-financial-results-2021-07-07
https://www.nasdaq.com/press-release/atricure-names-two-new-members-to-the-board-of-directors-2021-06-15
https://www.nasdaq.com/press-release/atricures-epi-sense-system-approved-by-fda-for-treatment-of-long-standing-persistent
https://www.nasdaq.com/press-release/atricure-reports-first-quarter-2021-financial-results-2021-04-27
https://www.nasdaq.com/press-release/atricure-names-b.-kristine-johnson-board-chair-2021-04-08
https://www.nasdaq.com/press-release/atricure-to-announce-first-quarter-2021-financial-results-2021-04-06
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-oppenheimer-31st-annual-healthcare-conference-2021-03
https://www.nasdaq.com/press-release/atricure-reports-fourth-quarter-2020-and-full-year-2020-financial-results-2021-02-23
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-svb-leerink-10th-annual-global-healthcare-conference
https://www.nasdaq.com/press-release/atricure-to-announce-fourth-quarter-and-full-year-2020-financial-results-2021-02-02
https://www.nasdaq.com/press-release/atricure-reports-preliminary-results-for-fourth-quarter-and-full-year-2020-2021-01-11
https://www.nasdaq.com/press-release/atricure-announces-labeling-expansion-for-cryo-nerve-block-therapy-2021-01-04
https://www.nasdaq.com/press-release/atricure-to-participate-in-the-39th-annual-j.p.-morgan-healthcare-conference-2020-12
https://www.nasdaq.com/press-release/atricure-to-participate-in-upcoming-piper-sandler-32nd-annual-virtual-healthcare
https://www.nasdaq.com/press-release/atricure-reports-third-quarter-2020-financial-results-2020-11-05
https://www.nasdaq.com/press-release/atricure-to-participate-in-upcoming-investor-conferences-2020-10-26
https://www.nasdaq.com/press-release/atricure-to-announce-third-quarter-2020-financial-results-2020-10-13
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-morgan-stanley-18th-annual-global-healthcare
https://www.nasdaq.com/press-release/atricure-announces-angie-wirick-as-chief-financial-officer-2020-08-06
https://www.nasdaq.com/press-release/atricure-to-participate-at-upcoming-investor-conferences-2020-07-29
https://www.nasdaq.com/press-release/atricure-reports-second-quarter-2020-financial-results-2020-07-28
https://www.nasdaq.com/press-release/atricure-to-announce-second-quarter-2020-financial-results-2020-07-07
https://www.nasdaq.com/press-release/atricure-announces-pricing-of-public-offering-of-common-stock-2020-05-11
https://www.nasdaq.com/press-release/atricure-announces-proposed-public-offering-of-common-stock-2020-05-11
https://www.nasdaq.com/press-release/atricure-announces-results-from-converge-ide-clinical-trial-2020-05-08
https://www.nasdaq.com/press-release/atricure-announces-investor-update-webcast-on-may-8-2020-in-conjunction-with-the-41st
https://www.nasdaq.com/press-release/atricure-reports-first-quarter-2020-financial-results-2020-04-29
https://www.nasdaq.com/press-release/atricure-to-participate-at-upcoming-investor-conferences-2020-04-27
https://www.nasdaq.com/press-release/atricure-to-announce-first-quarter-2020-financial-results-2020-04-15
https://www.nasdaq.com/press-release/atricure-announces-converge-ide-trial-results-accepted-for-late-breaking-clinical
https://www.nasdaq.com/press-release/atricure-announces-preliminary-financial-results-for-first-quarter-2020-and-provides
https://www.nasdaq.com/press-release/atricure-reports-fourth-quarter-2019-and-full-year-2019-financial-results-2020-02-18
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-svb-leerink-9th-annual-global-healthcare-conference
https://www.nasdaq.com/press-release/atricure-to-announce-fourth-quarter-and-full-year-2019-financial-results-2020-01-28
https://www.nasdaq.com/press-release/atricure-reports-preliminary-results-for-fourth-quarter-and-full-year-2019-provides
https://www.nasdaq.com/press-release/atricure-announces-successful-completion-of-patient-enrollment-of-amaze-clinical
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-38th-annual-jp-morgan-healthcare-conference-2019-12-16
https://www.nasdaq.com/press-release/atricure-names-two-industry-veterans-to-board-of-directors-2019-12-04
https://www.nasdaq.com/press-release/atricure-to-participate-at-the-piper-jaffray-31st-annual-healthcare-conference-2019
https://www.nasdaq.com/press-release/atricure-reports-third-quarter-2019-financial-results-2019-10-30
